Sign in or create an account to add this stock to your watchlist.
About Myomo (NYSEAMERICAN:MYO)
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:MYO
CUSIPN/A
Phone+1-617-9969058
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-257.70%
Return on Equity-155.42%
Return on Assets-73.21%
Miscellaneous
EmployeesN/A
Outstanding Shares12,410,000
Myomo (NYSEAMERICAN:MYO) Frequently Asked Questions
What is Myomo's stock symbol?
Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO."
How were Myomo's earnings last quarter?
Myomo (NYSEAMERICAN:MYO) released its earnings results on Wednesday, May, 9th. The company reported ($0.20) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.19) by $0.01. The company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.56 million. Myomo had a negative return on equity of 155.42% and a negative net margin of 257.70%. View Myomo's Earnings History.
What price target have analysts set for MYO?
2 equities research analysts have issued 1 year price objectives for Myomo's shares. Their forecasts range from $7.00 to $12.00. On average, they anticipate Myomo's share price to reach $9.50 in the next year. View Analyst Ratings for Myomo.
Are investors shorting Myomo?
Myomo saw a increase in short interest in the month of April. As of April 30th, there was short interest totalling 1,211,656 shares, an increase of 10.6% from the April 13th total of 1,095,830 shares. Based on an average daily volume of 612,579 shares, the short-interest ratio is currently 2.0 days. Approximately 11.7% of the shares of the company are sold short.
Who are some of Myomo's key competitors?
Some companies that are related to Myomo include Hamilton Thorne (HTL), Kromek Group (KMK), Electromed (ELMD), Universal Biosensors (UBI), Advanced Oncotherapy (AVO), Patient Home Monitoring (PHM), MRI Interventions (MRIC), Surgical Innovations (SUN), NeuroOne Medical Tech (NMTC), PetVivo (PETV), Avacta Group (AVCT), Airware Labs (AIRW), Inspiration Healthcare Group (IHC), HCi VioCare (VICA) and Arrhythmia Research Technology (MICR).
Who are Myomo's key executives?
Myomo's management team includes the folowing people:
- Mr. Paul R. Gudonis, Chairman, CEO & Pres (Age 63)
- Ms. Davie Mendelsohn RN, VP of Sales & Clinical Services (Age 64)
- Mr. Jonathan Naft CPO, VP & GM (Age 53)
- Mr. Ralph A. Goldwasser, CFO & Principal Accounting Officer (Age 70)
- Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 68)
Has Myomo been receiving favorable news coverage?
Media headlines about MYO stock have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Myomo earned a daily sentiment score of 0.22 on Accern's scale. They also gave headlines about the company an impact score of 47.88 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
Who are Myomo's major shareholders?
Myomo's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include A.R.T. Advisors LLC (0.75%) and Citadel Advisors LLC (0.33%). View Institutional Ownership Trends for Myomo.
Which institutional investors are buying Myomo stock?
How do I buy shares of Myomo?
Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Myomo's stock price today?
One share of MYO stock can currently be purchased for approximately $3.29.
How big of a company is Myomo?
Myomo has a market capitalization of $24.74 million.
How can I contact Myomo?
Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company can be reached via phone at +1-617-9969058.
MarketBeat Community Rating for Myomo (MYO)
MarketBeat's community ratings are surveys of what our community members think about Myomo and other stocks. Vote "Outperform" if you believe MYO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYO will underperform the S&P 500 over the long term. You may vote once every thirty days.
Myomo (NYSEAMERICAN:MYO) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Myomo in the last 12 months. Their average twelve-month price target is $9.50, suggesting that the stock has a possible upside of 188.75%. The high price target for MYO is $12.00 and the low price target for MYO is $7.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $9.50 | $10.50 | N/A | N/A |
| Price Target Upside: | 188.75% upside | 153.01% upside | N/A | N/A |
Myomo (NYSEAMERICAN:MYO) Consensus Price Target History
Myomo (NYSEAMERICAN:MYO) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 5/10/2018 | Roth Capital | Set Price Target | Buy | $9.00 ➝ $7.00 |  |
| 5/10/2018 | HC Wainwright | Set Price Target | Buy | $12.00 | |
(Data available from 5/23/2016 forward)
Myomo (NYSEAMERICAN:MYO) Earnings History and Estimates Chart
Myomo (NYSEAMERICAN MYO) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/9/2018 | Q1 2018 | ($0.19) | ($0.20) | $0.56 million | $0.31 million | View | N/A | |
| 3/7/2018 | Q4 2017 | ($0.33) | ($0.25) | $0.35 million | $0.55 million | View | N/A | |
| 11/6/2017 | Q3 2017 | ($0.30) | ($0.21) | $0.32 million | $0.49 million | View | N/A | |
| 8/14/2017 | Q2 2017 | | ($1.06) | | $0.31 million | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Myomo (NYSEAMERICAN:MYO) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Myomo (NYSEAMERICAN MYO) Insider Trading and Institutional Ownership History
Myomo (NYSEAMERICAN MYO) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Myomo (NYSEAMERICAN MYO) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | BRIEF-Myomo Says CMS Published Favorable Prelim Decision Regarding Application For Medicare Codes
www.reuters.com - May 14 at 11:06 AM |
 | Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision
finance.yahoo.com - May 14 at 11:06 AM |
 | Myomo up 28% premarket on likely Medicare reimbursement for MyoPro
seekingalpha.com - May 14 at 9:16 AM |
 | HC Wainwright Analysts Give Myomo (MYO) a $12.00 Price Target
www.americanbankingnews.com - May 10 at 7:05 PM |
| Myomo (MYO) Given a $7.00 Price Target by Roth Capital Analysts
www.americanbankingnews.com - May 10 at 5:37 PM |
| Myomo's (MYO) CEO Paul Gudonison Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 4:02 PM |
| Myomo's (MYO) CEO Paul Gudonis on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 10:19 AM |
| Myomo Reports First Quarter 2018 Results
finance.yahoo.com - May 10 at 10:19 AM |
| Myomo, Inc. Issues May 2018 Shareholder Letter
finance.yahoo.com - May 10 at 10:19 AM |
| Myomo (MYO) Sees Significant Growth in Short Interest
www.americanbankingnews.com - May 9 at 5:24 PM |
| Myomo (MYO) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - May 9 at 8:52 AM |
 | Myomo CEO uses a novel financial instrument to take orthotic company public
www.bizjournals.com - May 3 at 3:57 PM |
| Myomo to Report First Quarter 2018 Results on May 9, 2018
finance.yahoo.com - May 3 at 9:53 AM |
| Myomo Announces Free Screening Days in Over 20 Cities Nationwide
finance.yahoo.com - May 2 at 9:55 AM |
| Myomo (MYO) Sees Significant Drop in Short Interest
www.americanbankingnews.com - April 25 at 2:04 AM |
| Myomo perks up ahead of 60 minutes report on MIT Media Lab; shares ahead 12%
seekingalpha.com - April 20 at 4:02 PM |
| Myomo (MYO) Short Interest Down 1.2% in March
www.americanbankingnews.com - April 12 at 3:23 AM |
| HC Wainwright Reaffirms Buy Rating for Myomo (MYO)
www.americanbankingnews.com - April 7 at 10:28 PM |
| Short Interest in Myomo Inc (MYO) Rises By 6.4%
www.americanbankingnews.com - March 26 at 6:33 PM |
| Myomo (MYO) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - March 23 at 10:46 PM |
| Myomo (MYO) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 23 at 7:22 PM |
| SeeThruEquity Issues Update on Myomo, Inc.
finance.yahoo.com - March 22 at 10:19 AM |
| BRIEF-Myomo Inc - Qtrly Loss Per Share $0.25
www.reuters.com - March 17 at 10:23 AM |
| UPDATE - Myomo Reports Fourth Quarter and Year End 2017 Results
finance.yahoo.com - March 16 at 4:42 PM |
| Myomo Welcomes 13 New Center of Excellence Locations
finance.yahoo.com - March 12 at 9:50 AM |
| Short Interest in Myomo Inc (MYO) Expands By 12.8%
www.americanbankingnews.com - March 9 at 6:04 PM |
| Myomo (MYO) Earns Buy Rating from Analysts at Roth Capital
www.americanbankingnews.com - March 9 at 4:23 PM |
| Myomo (MYO) PT Set at $12.00 by HC Wainwright
www.americanbankingnews.com - March 8 at 10:30 PM |
| Myomo Reports Fourth Quarter and Year End 2017 Results
finance.yahoo.com - March 7 at 4:38 PM |
| Myomo to Present at the 30th Annual ROTH Conference
finance.yahoo.com - March 5 at 10:36 AM |
| Myomo Inc (MYO) Short Interest Up 3.4% in February
www.americanbankingnews.com - March 1 at 3:06 AM |
| Myomo to Report Fourth Quarter and Year End 2017 Results on March 7, 2018
finance.yahoo.com - February 28 at 10:02 AM |
| Myomo and GRE to Conduct Screening Days in Ohio and Detroit
finance.yahoo.com - February 14 at 8:47 AM |
| Myomo Inc (MYO) Sees Large Growth in Short Interest
www.americanbankingnews.com - February 9 at 8:06 PM |
| New Research: Key Drivers of Growth for Tallgrass Energy GP, LP, Lithia Motors, Akcea Therapeutics, Meridian Bioscience, Myomo, and Liberty Media — Factors of Influence, Major Initiatives and Sustained Production
finance.yahoo.com - February 6 at 8:42 AM |
| Short Interest in Myomo Inc (MYO) Drops By 3.3%
www.americanbankingnews.com - January 26 at 1:20 AM |
| Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center
finance.yahoo.com - January 24 at 9:04 AM |
| Myomo Inc (MYO) Short Interest Update
www.americanbankingnews.com - January 10 at 6:04 PM |
| Myomo, Inc. Announces Full Exercise of Underwriter’s Over-Allotment Option in Follow-On Public Offering
finance.yahoo.com - December 6 at 5:55 PM |
 | Myomo CEO Talks M&A Potential: Ossur, Ottobock 'Have Been Inquisitive In The Past'
www.benzinga.com - December 5 at 5:50 PM |
| BRIEF-Sabby Management LLC Reports A 5.54 Pct Passive Stake In Myomo Inc
www.reuters.com - December 5 at 9:14 AM |
| Myomo, Inc. (MYO)
finance.yahoo.com - November 30 at 9:00 AM |
 | Form S-1MEF MYOMO INC
www.streetinsider.com - November 30 at 9:00 AM |
| BRIEF-Myomo Inc Announces Pricing Of Public Offering
www.reuters.com - November 30 at 9:00 AM |
| Myomo, Inc. Announces Pricing of Public Offering
finance.yahoo.com - November 30 at 9:00 AM |
| Myomo, Inc. to Present at the 10th Annual LD Micro Main Event
finance.yahoo.com - November 28 at 10:17 AM |
| Myomo Inc (MYO) Sees Significant Increase in Short Interest
www.americanbankingnews.com - November 13 at 11:32 PM |
Myomo (NYSEAMERICAN:MYO) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Myomo (NYSEAMERICAN:MYO) Income Statement, Balance Sheet and Cash Flow Statement
Myomo (NYSEAMERICAN MYO) Stock Chart for Wednesday, May, 23, 2018
Loading chart…
